Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Oral Lactulose to Help GI Recovery After Complicated Appendicitis

Official title: Oral Lactulose for Postoperative Gastrointestinal Recovery After Complex Appendectomy: A Prospective Triple-Blind Placebo-Controlled Single-Center Randomized Trial

Run by Nanchong Central Hospital · NCT07589465 · Data updated 2026-11-12

This trial tests whether giving lactulose by mouth after appendectomy helps people recover bowel function faster than a placebo.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment150 (estimated)
SponsorNanchong Central Hospital
Government
Locations1 site (Sichuan)
StatusRecruiting
StartedJune 21, 2026
Main results expectedJune 30, 2029
Study endsJune 30, 2029
Registry record updatedJune 25, 2026
Trial IDNCT07589465 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing open or laparoscopic surgery for complicated appendicitis with consent and ability to follow up.

Probably not a fit

Patients with preexisting intestinal obstruction, inflammatory bowel disease, tumors, or other exclusion criteria may not benefit and could be at higher risk for adverse events.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this single-center, triple-blind, randomized study, adults undergoing appendectomy for complicated appendicitis will receive lactulose or a placebo on postoperative days 1 and 2. The main goal is to see how long it takes until the patient can tolerate solids or have their first bowel movement (GI-2). Secondary outcomes include time to first flatulence, 72-hour defecation rate, nausea/vomiting, length of hospital stay, costs, complications, and any lactulose-related side effects. Researchers will enroll 150 participants and compare outcomes between the two groups to determine if early oral lactulose can promote faster gastrointestinal recovery. The trial is designed to provide high-quality evidence to guide postoperative care in this setting.

Why it matters

Potential benefit: If successful, patients may recover GI function faster, potentially shortening hospital stays and improving comfort after surgery.

How similar studies have gone: Previous research on gut motility agents after abdominal surgery has shown mixed results; this design aims to provide clearer, high-level evidence for lactulose.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1.Age ≥18 years.2.Complicated appendicitis confirmed by SAS2.0 score, intraoperative findings, or pathology.3.Undergoing appendectomy (open or laparoscopic).4.Able to provide informed consent and comply with follow-up.

Exclusion Criteria:

* 1.Preoperative intestinal obstruction, IBD, or intestinal tumor.2.Planned postoperative fasting \>48 hours.3.Hypersensitivity to lactulose or placebo.4.Severe organ dysfunction (ASA ≥IV).5.Pregnancy or lactation.6.Cognitive or psychiatric disorder impairing follow-up.

Where it's running

  • Beijing Anzhen Hospital Nanchong Hospital Affiliated to Capital Medical University, Nanchong, Sichuan 637000
    Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.